The global downstream processing market continues its remarkable growth trajectory, fueled by increasing adoption across biopharmaceutical companies and contract research organizations. According to recent market analysis, the market, valued at USD 24.9 Billion in 2022, is anticipated to reach a valuation of USD 72.3 Billion by the end of 2032. This robust growth is expected to continue, with a projected compound annual growth rate (CAGR) of 11.3% between 2022 and 2032.
Downstream processing is integral to the production of biopharmaceuticals, employing various techniques to purify and isolate desired molecules from complex biological mixtures. With rising demand for biopharmaceuticals and ongoing advancements in bioprocessing technologies, the downstream processing market is experiencing unprecedented expansion.
Get Sample Copy of Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-5070
This growth is attributed to several key factors, including:
- Increased demand for biopharmaceuticals: The growing demand for biopharmaceuticals, such as vaccines and therapeutic proteins, is driving the need for efficient and scalable downstream processing solutions.
- Rising adoption by CROs: CROs are increasingly outsourcing downstream processing activities, which is further fueling market growth.
- Technological advancements: Advancements in downstream processing technologies, such as single-use systems and continuous processing, are improving efficiency and reducing costs.
This expansion presents an exciting opportunity for companies involved in the development and manufacturing of downstream processing products and services. As the market continues to grow, there will be a strong demand for innovative solutions that can meet the evolving needs of biopharmaceutical companies and CROs.
Forecast Highlights on Global Downstream Processing Market:
- As per the forecast of Future Market Insights, the filters product type segment is slated to touch a value of nearly USD 5,700 Million in the year 2022. This represents a robust CAGR during the assessment period of 2017-2022. The filters product type segment is estimated to account for more than one-fifth of the revenue share of the product type segment by the year 2017 and is forecasted to lose market share by 2022 over 2017.
- As per the forecast of Future Market Insights, the contract manufacturing organizations segment will reach a value of nearly USD 5,500 Million in the year 2017. This represents a robust CAGR growth during the forecast period. The contract manufacturing organizations segment is forecasted to account for more than one-third of the total revenue share of the end users segment by the end of the year 2017 and is expected to lose in market share by 2022 as compared with the year 2017.
- As per the forecast of Future Market Insights, the monoclonal antibody production segment is slated to reach a value of about USD 8,300 Million in 2022. The monoclonal antibody production segment is expected to gain market share by the end of the year 2022. The largest share is contributed by the North America region in the monoclonal antibody production segment.
- Future Market Insights forecasts the gel chromatography segment to exhibit a compound annual growth rate (CAGR) of nearly 15.0% from 2017 to 2022.
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-5070
Key Companies Profiled:
- Thermo Fisher Scientific Inc.
- GE Healthcare
- Sartorius Stedim Biotech S.A.
- Merck Millipore
- Danaher Corporation
- 3M Company
- Boehringer Ingelheim
- Lonza Group AG
- Eppendorf AG
- Finesse Solutions, Inc.
- Bio-Rad Laboratories
- Agilent technologies
- Solida Biotech GmBH
- Waters Corporation
- Applikon BioTechnique/Getinge AB
Key Market Segments Covered In the Downstream Processing Industry Research:
By Product:
- Chromatography Columns and Resins
- Membrane Adsorbers
- Single-use Products
- Consumables and Accessories
By Technique:
- Separation
- Concentration
- Purification
By Application:
- Monoclonal Antibody Production
- Vaccine Production
- Insulin Production
- Immunoglobulin Production
- Erythropoietin Production
- Other Application
By End User:
- Biopharmaceutical Companies
- CDMO/Contract Research Organization
- Research/Academic Institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Get Full Report Now: https://www.futuremarketinsights.com/checkout/5070
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
